Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome Publication Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…CertaraJune 28, 2023
American College of Toxicology 2025 Annual Meeting Conference American College of Toxicology 2025 Annual Meeting – – BoothCertaraMay 24, 2023
Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics Publication Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics Perhaps the most important lesson learned from the COVID‐19 pandemic is that of preparedness. Enhanced…CertaraMay 11, 2021
Purity is a Virtue: A Practical Guide to the Reporting of Impurities On-Demand Webinar Purity is a Virtue: A Practical Guide to the Reporting of Impurities Many pharmaceutical companies struggle with characterizing drug substance (DS) and drug product (DP) impurities and…CertaraMarch 23, 2021
Optimize Immuno-oncology Drug Discovery and Development Using QSP White Paper Optimize Immuno-oncology Drug Discovery and Development Using QSP A Quantitative Systems Pharmacology (QSP) approach for developing combination immune-oncology therapies can be used to…CertaraJune 19, 2019
7 Things to Know About the China Pharmaceutical Industry Blog 7 Things to Know About the China Pharmaceutical Industry China is the second largest pharmaceutical market in the world. Demand is likely to increase…CertaraOctober 16, 2018
Pharmacokinetic/ Toxicokinetic Services Brochure Pharmacokinetic/ Toxicokinetic Services As your partner for drug development and regulatory strategy, Certara has expanded its services to…CertaraMay 18, 2018
Changing the Game in Drug Development Brochure Changing the Game in Drug Development At Certara, we are innovators, dedicated to helping our clients develop new therapies and target…CertaraMarch 19, 2018